This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Most patients have unrecognised signs and symptoms for many years and may be diagnosed through a dental examination or testing done for other reasons.1,2 Although their outward appearance may have altered, it is often the symptoms of complications that lead patients to seek medical care.1
The diagnosis can be confirmed with an Oral Glucose Tolerance Test (OGTT) or measurement of serum IGF-I levels (age and sex-adjusted). Although both growth hormone (GH) and IGF-I levels have been implicated as indicators of mortality, IGF-I is considered to be indicative of persistent clinical disease activity.3
Imaging techniques such as computed tomography (CT) or magnetic resonance imaging (MRI) are used to determine the cause of GH overproduction (usually a pituitary adenoma) and provide further confirmation of the acromegaly diagnosis.2,4,5
To find out more about homecare, supporting patients or ordering more starter kits
Help find your Somavert patient's personal optimum by titrating doses
References:
Discover IGF-I normalisation rates with Somavert
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024